Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2021 Jul 2

PMID 34211570

Citations 28

Authors

Anurag Kumar Singh

Sachchida Nand Rai

Anand Maurya

Gaurav Mishra

Rajendra Awasthi

Anshul Shakya

Dinesh Kumar Chellappan

Kamal Dua

Emanuel Vamanu

Sushil Kumar Chaudhary

M P Singh

Affiliations

Soon will be listed here.

Abstract

Since primitive times, herbs have been extensively used in conventional remedies for boosting cognitive impairment and age-associated memory loss. It is mentioned that medicinal plants have a variety of dynamic components, and they have become a prominent choice for synthetic medications for the care of cognitive and associated disorders. Herbal remedies have played a major role in the progression of medicine, and many advanced drugs have already been developed. Many studies have endorsed practicing herbal remedies with phytoconstituents, for healing Alzheimer's disease (AD). All the information in this article was collated from selected research papers from online scientific databases, such as PubMed, Web of Science, and Scopus. The aim of this article is to convey the potential of herbal remedies for the prospect management of Alzheimer's and related diseases. Herbal remedies may be useful in the discovery and advancement of drugs, thus extending new leads for neurodegenerative diseases such as AD. Nanocarriers play a significant role in delivering herbal medicaments to a specific target. Therefore, many drugs have been described for the management of age-linked complaints such as dementia, AD, and the like. Several phytochemicals are capable of managing AD, but their therapeutic claims are restricted due to their lower solubility and metabolism. These limitations of natural therapeutics can be overcome by using a targeted nanocarrier system. This article will provide the primitive remedies as well as the development of herbal remedies for AD management.

Citing Articles

The Potential Role of Phytochemicals in Alzheimer's Disease.

Baranowska-Wojcik E, Gajowniczek-Alasa D, Pawlikowska-Pawlega B, Szwajgier D Nutrients. 2025; 17(4).

PMID: 40004981 PMC: 11858096. DOI: 10.3390/nu17040653.

Therapeutic Options in Alzheimer's Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity.

Cacabelos R, Martinez-Iglesias O, Cacabelos N, Carrera I, Corzo L, Naidoo V Life (Basel). 2025; 14(12.

PMID: 39768263 PMC: 11678002. DOI: 10.3390/life14121555.

Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.

Tripathi P, Lodhi A, Rai S, Kumar Nandi N, Dumoga S, Yadav P Degener Neurol Neuromuscul Dis. 2024; 14:47-74.

PMID: 38784601 PMC: 11114142. DOI: 10.2147/DNND.S452009.

Tangeretin confers neuroprotection, cognitive and memory enhancement in global cerebral ischemia in rats.

Alla N, Palatheeya S, Challa S, Kakarla R 3 Biotech. 2023; 14(1):9.

PMID: 38074289 PMC: 10709536. DOI: 10.1007/s13205-023-03854-y.

Hyperphosphorylated Tau Inflicts Intracellular Stress Responses that Are Mitigated by Apomorphine.

Song Z, Wang K, Chien Hagar H, Chen H, Kuan C, Zhang K Mol Neurobiol. 2023; 61(5):2653-2671.

PMID: 37919601 PMC: 11043184. DOI: 10.1007/s12035-023-03689-x.

References

Kumar P, Sharma G, Kumar R, Singh B, Malik R, Katare O . Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences. Int J Pharm. 2016; 515(1-2):307-314. DOI: 10.1016/j.ijpharm.2016.10.024. View

Mori T, Rezai-Zadeh K, Koyama N, Arendash G, Yamaguchi H, Kakuda N . Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem. 2012; 287(9):6912-27. PMC: 3307267. DOI: 10.1074/jbc.M111.294025. View

Funk J, Frye J, Oyarzo J, Kuscuoglu N, Wilson J, McCaffrey G . Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis Rheum. 2006; 54(11):3452-64. DOI: 10.1002/art.22180. View

Luo Y . Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease. J Alzheimers Dis. 2002; 3(4):401-407. DOI: 10.3233/jad-2001-3407. View

Singh A, Mishra G, Maurya A, Awasthi R, Kumari K, Thakur A . Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles. Curr Alzheimer Res. 2019; 16(13):1216-1229. DOI: 10.2174/1567205016666190903102822. View

Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K . Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model. J Ethnopharmacol. 2009; 127(1):26-31. DOI: 10.1016/j.jep.2009.09.056. View

Ardura-Fabregat A, Boddeke E, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzeriat K . Targeting Neuroinflammation to Treat Alzheimer's Disease. CNS Drugs. 2017; 31(12):1057-1082. PMC: 5747579. DOI: 10.1007/s40263-017-0483-3. View

Matsuda H, Murakami T, Kishi A, Yoshikawa M . Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. 2001; 9(6):1499-507. DOI: 10.1016/s0968-0896(01)00024-4. View

Yuan S, Zhao Y . [A novel phlegmariurine type alkaloid from Huperzia serrata (Thunb.) Trev]. Yao Xue Xue Bao. 2003; 38(8):596-8. View

10.

Valles S, Borras C, Gambini J, Furriol J, Ortega A, Sastre J . Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38. Aging Cell. 2007; 7(1):112-8. DOI: 10.1111/j.1474-9726.2007.00356.x. View

11.

Dhanasekaran M, Tharakan B, Holcomb L, Hitt A, Young K, Manyam B . Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phytother Res. 2007; 21(10):965-9. DOI: 10.1002/ptr.2195. View

12.

Huo X, Zhang Y, Jin X, Li Y, Zhang L . A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease. J Photochem Photobiol B. 2018; 190:98-102. DOI: 10.1016/j.jphotobiol.2018.11.008. View

13.

Kikuchi K, Kidana K, Tatebe T, Tomita T . Dysregulated Metabolism of the Amyloid-β Protein and Therapeutic Approaches in Alzheimer Disease. J Cell Biochem. 2017; 118(12):4183-4190. DOI: 10.1002/jcb.26129. View

14.

Gil B, Sanz M, Terencio M, Gunasegaran R, Paya M, Alcaraz M . Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity. Biochem Pharmacol. 1997; 53(5):733-40. DOI: 10.1016/s0006-2952(96)00773-3. View

15.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G . Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21(3):383-421. PMC: 3887148. DOI: 10.1016/s0197-4580(00)00124-x. View

16.

Cho I . Effects of Panax ginseng in Neurodegenerative Diseases. J Ginseng Res. 2013; 36(4):342-53. PMC: 3659610. DOI: 10.5142/jgr.2012.36.4.342. View

17.

Tsai T . Concurrent measurement of unbound genistein in the blood, brain and bile of anesthetized rats using microdialysis and its pharmacokinetic application. J Chromatogr A. 2005; 1073(1-2):317-22. DOI: 10.1016/j.chroma.2004.10.048. View

18.

Norden D, Godbout J . Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol Appl Neurobiol. 2012; 39(1):19-34. PMC: 3553257. DOI: 10.1111/j.1365-2990.2012.01306.x. View

19.

Cai Z, Liu N, Wang C, Qin B, Zhou Y, Xiao M . Role of RAGE in Alzheimer's Disease. Cell Mol Neurobiol. 2015; 36(4):483-95. PMC: 11482350. DOI: 10.1007/s10571-015-0233-3. View

20.

Asai M, Iwata N, Yoshikawa A, Aizaki Y, Ishiura S, Saido T . Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Abeta secretion. Biochem Biophys Res Commun. 2006; 352(2):498-502. DOI: 10.1016/j.bbrc.2006.11.043. View